| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9229 |
| Human Intestinal Absorption | HIA+ | 0.9586 |
| Caco-2 Permeability | Caco2+ | 0.7209 |
| P-glycoprotein Substrate | Non-substrate | 0.5603 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.7673 |
| Non-inhibitor | 0.8935 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8410 |
| Distribution |
| Subcellular localization | Mitochondria | 0.9030 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8072 |
| CYP450 2D6 Substrate | Non-substrate | 0.8651 |
| CYP450 3A4 Substrate | Non-substrate | 0.5244 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.5231 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.6633 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9102 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.6831 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8958 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8044 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9471 |
| Non-inhibitor | 0.9402 |
| AMES Toxicity | Non AMES toxic | 0.8538 |
| Carcinogens | Non-carcinogens | 0.6986 |
| Fish Toxicity | High FHMT | 0.9844 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9986 |
| Honey Bee Toxicity | High HBT | 0.6072 |
| Biodegradation | Ready biodegradable | 0.6951 |
| Acute Oral Toxicity | IV | 0.7664 |
| Carcinogenicity (Three-class) | Warning | 0.5182 |